BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33086767)

  • 21. Heterozygote deficiency in thymidylate synthase enhancer region polymorphism genotype distribution in Hungarian colorectal cancer patients.
    Adleff V; Hitre E; Köves I; Orosz Z; Hajnal A; Kralovánszky J
    Int J Cancer; 2004 Mar; 108(6):852-6. PubMed ID: 14712487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of methylenetetrahydrofolate reductase (MTHFR 677C>T) and thymidylate synthase (TSER and TS 1494del6) polymorphisms with premature ovarian failure in Korean women.
    Rah H; Jeon YJ; Choi Y; Shim SH; Yoon TK; Choi DH; Cha SH; Kim NK
    Menopause; 2012 Nov; 19(11):1260-6. PubMed ID: 22713864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer.
    Romiti A; Roberto M; D'Antonio C; Onesti CE; Barucca V; Milano A; Gentile G; Lionetto L; Medda E; Mazzuca F; Botticelli A; Falcone R; Simmaco M; Marchetti P
    Anticancer Drugs; 2016 Nov; 27(10):1044-9. PubMed ID: 27557140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms of 5,10-methylenetetrahydrofolate reductase (MTHFR C677T) and thymidylate synthase enhancer region (TSER) as a risk factor of cholangiocarcinoma in a Korean population.
    Ko KH; Kim NK; Yim DJ; Hong SP; Park PW; Rim KS; Kim S; Hwang SG
    Anticancer Res; 2006; 26(6B):4229-33. PubMed ID: 17201138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The thymidylate synthase enhancer region (TSER) polymorphism increases the risk of thymic lymphoid hyperplasia in patients with Myasthenia Gravis.
    Lopomo A; Ricciardi R; De Rosa A; Guida M; Maestri M; Lucchi M; Melfi F; Mussi A; Migliore L; Coppedè F
    Gene; 2018 Feb; 642():376-380. PubMed ID: 29162511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of combined methylenetetrahydrofolate reductase (MTHFR) and thymidylate synthase enhancer region (TSER) polymorphisms to plasma homocysteine levels in Korean patients with recurrent spontaneous abortion.
    Kim NK; Choi YK; Kang MS; Choi DH; Cha SH; An MO; Lee S; Jeung M; Ko JJ; Oh D
    Thromb Res; 2006; 117(6):653-8. PubMed ID: 15985285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TYMS and DPYD polymorphisms in a Turkish population.
    Süzen HS; Yüce N; Güvenç G; Duydu Y; Erke T
    Eur J Clin Pharmacol; 2005 Dec; 61(12):881-5. PubMed ID: 16328315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphism in Thymidylate Synthase Gene Predicts Survival and Toxicity in North Indian Lung Cancer Patients Undergoing Platinum-Based Doublet Chemotherapy.
    Sharma P; Singh N; Sharma S
    Oncology; 2022 Jan; ():. PubMed ID: 35086099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms of thymidylate synthase gene 5'- and 3'-untranslated region and risk of gastric cancer in Koreans.
    Yim DJ; Kim OJ; An HJ; Kang H; Ahn DH; Hwang SG; Oh D; Kim NK
    Anticancer Res; 2010 Jun; 30(6):2325-30. PubMed ID: 20651387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymidylate synthase enhancer region polymorphism not related to susceptibility to acute lymphoblastic leukemia in the Kashmir population.
    Nazki FH; Masood A; Banday MA; Bhat A; Ganai BA
    Genet Mol Res; 2012 Apr; 11(2):906-17. PubMed ID: 22576918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil.
    Cascinu S; Aschele C; Barni S; Debernardis D; Baldo C; Tunesi G; Catalano V; Staccioli MP; Brenna A; Muretto P; Catalano G
    Clin Cancer Res; 1999 Aug; 5(8):1996-9. PubMed ID: 10473077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients.
    Amatori F; Di Paolo A; Del Tacca M; Fontanini G; Vannozzi F; Boldrini L; Bocci G; Lastella M; Danesi R
    Pharmacogenet Genomics; 2006 Nov; 16(11):809-16. PubMed ID: 17047489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients.
    Sharma R; Hoskins JM; Rivory LP; Zucknick M; London R; Liddle C; Clarke SJ
    Clin Cancer Res; 2008 Feb; 14(3):817-25. PubMed ID: 18245544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.
    Lecomte T; Ferraz JM; Zinzindohoué F; Loriot MA; Tregouet DA; Landi B; Berger A; Cugnenc PH; Jian R; Beaune P; Laurent-Puig P
    Clin Cancer Res; 2004 Sep; 10(17):5880-8. PubMed ID: 15355920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G>C SNP of thymidylate synthase with respect to colorectal cancer.
    Gusella M; Padrini R
    Pharmacogenomics; 2007 Aug; 8(8):985-96. PubMed ID: 17716232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic variants in the enhancer region of the thymidylate synthase gene in the Chilean population.
    Acuña M; Eaton L; Cifuentes L; Massardo D
    Br J Clin Pharmacol; 2006 Jun; 61(6):778-82. PubMed ID: 16722845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between polymorphisms within the thymidylate synthase gene and spina bifida.
    Volcik KA; Shaw GM; Zhu H; Lammer EJ; Laurent C; Finnell RH
    Birth Defects Res A Clin Mol Teratol; 2003 Nov; 67(11):924-8. PubMed ID: 14745930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case-control analysis of thymidylate synthase polymorphisms and risk of lung cancer.
    Shi Q; Zhang Z; Neumann AS; Li G; Spitz MR; Wei Q
    Carcinogenesis; 2005 Mar; 26(3):649-56. PubMed ID: 15579479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymidylate synthase polymorphisms and colon cancer: associations with tumor stage, tumor characteristics and survival.
    Curtin K; Ulrich CM; Samowitz WS; Bigler J; Caan B; Potter JD; Slattery ML
    Int J Cancer; 2007 May; 120(10):2226-32. PubMed ID: 17290389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism.
    Peters GJ; Backus HH; Freemantle S; van Triest B; Codacci-Pisanelli G; van der Wilt CL; Smid K; Lunec J; Calvert AH; Marsh S; McLeod HL; Bloemena E; Meijer S; Jansen G; van Groeningen CJ; Pinedo HM
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):194-205. PubMed ID: 12084461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.